Table 2.

Comparison of main signs and symptoms between survivors and non-survivors patients with visceral leishmaniasis

	Non-survivors (N = 34)	Survivors (N = 251)	p
Fever	30 (88.2%)	229 (91.2%)	0.569
Hepato-splenomegaly	22 (64.7%)	199 (79.3%)	0.056
Weight loss	22 (64.7%)	185 (74%)	0.253
Asthenia	16 (47.1%)	156 (62.2%)	0.091
Cough	13 (38.2%)	95 (37.8%)	0.965
Abdominal pain	15 (44.1%)	84 (33.5%)	0.221
Diarrhea	12(35.3%)	57 (22.7%)	0.108
Vomiting	13 (38.2%)	54 (21.5%)	0.031
Dyspnea	13 (38.2%)	42 (16.7%)	0.003
Edema	11 (32.4%)	42 (16.7%)	0.028
Jaundice	16 (47.1%)	36 (14.3%)	<0.001
Dehydration	8 (23.5%)	27 (10.8%)	0.033
Nose bleeding	11 (4.8%)	13 (5.2%)	0.128
Pulmonary crackles	4 (11.8%)	10 (4.0%)	0.049
Oliguria	3 (8.8%)	2 (0.8%)	0.001
Hypotension	0 (0%)	2 (0.8%)	0.602

Chi-squared test was used. P ≤ 0.05 was considered statistically significant